CorMedix Inc (NASDAQ: CRMD) kicked off on Tuesday, up 1.10% from the previous trading day, before settling in for the closing price of $10.94. Over the past 52 weeks, CRMD has traded in a range of $3.61-$17.43.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 29.80%. While this was happening, its average annual earnings per share was recorded 455.24%. With a float of $72.39 million, this company’s outstanding shares have now reached $74.43 million.
Let’s determine the extent of company efficiency that accounts for 65 employees. In terms of profitability, gross margin is 95.19%, operating margin of 17.53%, and the pretax margin is 20.81%.
CorMedix Inc (CRMD) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of CorMedix Inc is 2.75%, while institutional ownership is 32.23%. The most recent insider transaction that took place on Oct 31 ’24, was worth 14,985. In this transaction EVP, Chief Commercial Officer of this company bought 1,500 shares at a rate of $9.99, taking the stock ownership to the 52,011 shares. Before that another transaction happened on Nov 14 ’24, when Company’s EVP sold 140,027 for $11.18, making the entire transaction worth $1,565,670. This insider now owns 45,397 shares in total.
CorMedix Inc (CRMD) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 455.24% per share during the next fiscal year.
CorMedix Inc (NASDAQ: CRMD) Trading Performance Indicators
Take a look at CorMedix Inc’s (CRMD) current performance indicators. Last quarter, stock had a quick ratio of 3.99. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9.97.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.23, a number that is poised to hit 0.17 in the next quarter and is forecasted to reach 1.79 in one year’s time.
Technical Analysis of CorMedix Inc (CRMD)
Looking closely at CorMedix Inc (NASDAQ: CRMD), its last 5-days average volume was 1.43 million, which is a drop from its year-to-date volume of 1.69 million. As of the previous 9 days, the stock’s Stochastic %D was 14.47%.
During the past 100 days, CorMedix Inc’s (CRMD) raw stochastic average was set at 46.15%, which indicates a significant increase from 31.03% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.40 in the past 14 days, which was lower than the 0.60 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $12.66, while its 200-day Moving Average is $10.53. However, in the short run, CorMedix Inc’s stock first resistance to watch stands at $11.24. Second resistance stands at $11.42. The third major resistance level sits at $11.69. If the price goes on to break the first support level at $10.79, it is likely to go to the next support level at $10.52. Should the price break the second support level, the third support level stands at $10.34.
CorMedix Inc (NASDAQ: CRMD) Key Stats
The company with the Market Capitalisation of 823.18 million has total of 67,825K Shares Outstanding. Its annual sales at the moment are 43,470 K in contrast with the sum of -17,930 K annual income. Company’s last quarter sales were recorded 39,080 K and last quarter income was 20,640 K.
